Globus Medical (GMED) PT Raised to $106 at Barclays
Tweet Send to a Friend
Barclays analyst Matt Miksic raised the price target on Globus Medical (NYSE: GMED) to $106.00 (from $103.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
